Indian Drug Companies Urge Government To Pass Data Exclusivity Law

Law360, New York (April 14, 2004, 12:00 AM EDT) -- Indian pharmaceutical companies have urged the government to pass legislation on data protection exclusivity.

An industry group presented their views to a government committee on Tuesday, arguing that they need protection for their data on new drugs from unfair commercial use under Article 39.3 of the World Trade Organization agreement on Trade Related aspects of Intellectual Property Rights (TRIPS).

The committee, headed by chemicals and petrochemicals secretary Pratyush Sinha, heard arguments by the Indian Drug Manufacturers’ Association (IDMA), the Organisation of Pharmaceutical Producers of India (OPPI)...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.